Thus, we differentiated human PSCs from familial PD patients harboring the LRRK2 G2019S mutation and from sporadic PD patients into neuronal cells containing dopaminergic neurons, which are known to be affected by PD progression. Here, LRRK2 is linked to Parkinson disease.